Structure (35eb525b 72a5 4ef9 A36a 531e9e6b3560 01)
Xopenex
Product Images NDC 21695-153
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Xopenex (NDC 21695-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 02)
The text represents a chart or a graph showing the mean change in FEV, which is an abbreviation of Forced Expiratory Volume, measured in percentage (%), against time (hours). The data points for each treatment are represented by different symbols - a circle (o), a square (e), a triangle (a), and a horizontal line (-) for Lev 1.25, Lev 0.63, Rac2.5, and PBO (placebo) treatments, respectively. The sample size (n) for each treatment is also provided. The chart shows that all treatments resulted in a 15% increase in FEV at the end of the study, which lasted for 8 hours.*
Figure 2 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 03)
This is a chart showing the mean change in FEV (Forced Expiratory Volume) in percentage for four different treatments: Lev 1.25, Lev 0.63, Rac2.5, and PBO (Placebo). The chart also displays the number of participants (n) for each treatment. The x-axis represents time in hours, and the y-axis represents the percentage change in FEV. The chart shows that Lev 1.25 had the highest mean change in FEV followed by Lev 0.63, Rac2.5, and PBO. The chart is incomplete as it only shows data for the first three hours, with a mean change of 15%.*
Figure 3 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 04)
Figure 4 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 05)
Figure 1 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 06)
Figure 2 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 07)
Figure 3 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 08)
Figure 4 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 09)
Xopenex 1.25mg/3ml (35eb525b 72a5 4ef9 A36a 531e9e6b3560 10)
This is a product label for Xopenex, which comes in the form of 2 unit-dose vials containing 1.26mg/3ml medication. The product has a National Drug Code (NDC) of 21695-153-24 and a product ID of RX015324. The rest of the text is not-readable due to errors.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
